Clear ×
MetaVia Inc. MTVA

Showing 10-K, 10-Q & 8-K from the last 6 months. Need full history or all form types?

Apr 10, 2026 8-K 1 signal fired
Core
Clinical Trial Result
Jan 27, 2026 8-K 1 signal fired
Other
Form S3 Shelf Registration Disclosure
Jan 16, 2026 8-K 13 signals fired
Other
Market Price Definition Ipo Net Proceeds Disclosure Form S3 Shelf Registration Disclosure Amendment Modification Waiver Clause Interim Data Positive Institutional Investment Use Of Proceeds Disclosure Warrant Redemption Cashless Exercise Provision Ipo Or Capital Raising Completion Warrant Exercise Share Delivery
Core
Clinical Trial Result Clinical Hold Lead Asset Progress
Jan 5, 2026 8-K 13 signals fired
Core
Clinical Trial Result Secondary Endpoint Mentioned Clinical Hold Combination Therapy Mentioned Indication Expansion Lead Asset Progress
Other
Patient Retention High Interim Data Positive Competition Disclosure Safety Differentiated Fda Aligned Publication Positive Enrollment Ahead Of Schedule
Jan 5, 2026 8-K 1 signal fired
Other
Liquidity Position Snapshot Disclosed
Dec 19, 2025 8-K 1 signal fired
Other
Nasdaq Minimum Bid Price Delisting Notice
Dec 2, 2025 8-K 4 signals fired
Other
Reverse Stock Split Effected Nyse Listing Disclosure Form S3 Shelf Registration Disclosure Fractional Share Cash Payment
Nov 26, 2025 8-K 1 signal fired
Other
Nasdaq Minimum Bid Price Delisting Notice
Nov 7, 2025 8-K 11 signals fired
Core
Clinical Trial Result Lead Asset Progress Indication Expansion Clinical Hold Combination Therapy Mentioned Near Term Regulatory Decision
Other
Patient Retention High Interim Data Positive Safety Differentiated Publication Positive Priority Review Or Pdufa Disclosed
Nov 6, 2025 10-Q 20 signals fired · top 15
Other
Net Loss Reported Financing Activities Cash Flow Disclosure Administrative Efficiency Personnel Cost Decrease Disclosure Institutional Investment Effective Tax Rate Reconciliation Tax Cuts And Jobs Act Disclosure Burn Rate Controlled Ipo Or Capital Raising Completion Shares Outstanding Disclosure Other Income Expense Disclosure Major Tax Law Change Impact
Core
Indication Expansion Clinical Hold
Business Services
Demand Softening